INTRODUCTION
============

A large number of genes are periodically transcribed during cell cycle progression in eukaryotic cells. These genes often encode cyclins---transcription factors and protein kinases with roles in normal cell cycle progression. The observed gene expression patterns are required for normal growth and may be perturbed in cancer cells ([@B25]; [@B12]). In fission yeast, ∼87 genes (denoted cluster 1) are activated at mitosis and repressed in G~1~ of the next cell cycle ([@B19]), and periodic control of their transcription is linked to quantitative changes in cyclin-dependent kinase 1 (Cdk1) activity ([@B1]). Transcription of a subset of these genes is regulated by two forkhead transcription factors, Sep1 and Fkh2, which have opposing effects on cluster 1 expression. Whereas loss of Sep1 causes reduced transcription of mitotic genes, loss of Fkh2 elevates M-phase transcription levels. Further underscoring this Yin and Yang relationship, Sep1 is found associated with cluster 1 promoters during gene activation, whereas Fkh2 associates with repressed promoters ([@B15]).

The multiprotein Mediator complex is a coregulator of RNA polymerase II (Pol II) transcription ([@B7]). Mediator forms a physical bridge that transduces regulatory information from gene-specific transcription factors (activators and repressors) to the Pol II transcription machinery as it assembles on the promoter ([@B8]). Mediator stimulates basal transcription, supports activated transcription, and enhances TFIIH-dependent phosphorylation of the C-terminal domain of Pol II ([@B17]; [@B3]; [@B11]).

In fission yeast, Mediator consists of a core complex of 15 subunits, which can associate with a four-component Cdk8 module containing Med12, Med13, Cdk8, and cyclin C (CycC) to form a larger form of Mediator (L-Mediator). Whereas core Mediator can bind Pol II, Mediator associated with the Cdk8 module is always isolated in the free form, devoid of Pol II ([@B20]; [@B10]; [@B5]). The Cdk8 module is targeted by a number of different intracellular signaling pathways, and the kinase activity has been shown to phosphorylate different molecular targets involved in transcription regulation ([@B23]). In contrast to the situation in many other eukaryotes, the conserved Med15 protein is not a stable component of fission yeast Mediator. Instead, Med15 forms a complex with Hrp1, a CHD1 ATP-dependent chromatin-remodeling protein. The Med15--Hrp1 complex can associate with L-Mediator, and the subcomplex plays a role in the regulated transcription of some fission yeast genes ([@B13]).

In previous work, we demonstrated that Cdk8 is required for correct timing of mitotic entry in fission yeast ([@B22]). The kinase phosphorylates Fkh2 in a cell cycle--dependent manner, which in turn prevents proteolysis and leads to oscillation of cellular Fkh2 levels. Inactivation of the Cdk8 kinase activity or mutation of the Fkh2 phosphorylation sites leads to delayed mitotic entry. In contrast, replacement of the targeted Fkh2 serine residues with glutamic acid---a mutation that mimics phosphorylation---causes premature mitotic entry. How Cdk8 is regulated is not well understood, but other Mediator components appear to influence its activities. Cdk8 is anchored to Mediator via Med12 and Med13, and loss of these anchoring proteins causes premature phosphorylation of Fkh2 and, as a consequence, early entry into mitosis ([@B2]). In contrast to other Cdks, Cdk8 is not activated by T-loop phosphorylation because its putative T-loop lacks a phosphoacceptor site. In addition, the concentration of its cognate cyclin, CycC, does not change during cell cycle progression ([@B14]). Instead, CycC forms a stable complex with Med12, Med13, and Cdk8 ([@B4]). The molecular mechanisms leading to temporal activation of Cdk8 remain unclear.

In contrast to Cdk8, a requirement for CycC for timing of M-phase progression has not been demonstrated. The cyclin was first identified in a search for mammalian and *Drosophila* genes that could rescue a yeast strain lacking G~1~ cyclins ([@B14]). A physiological role for CycC in G~1~ regulation, however, has been difficult to demonstrate. CycC contains a conserved surface groove, which forms interactions with the N-terminus of Med12. Oncogenic mutations in this region of Med12 uncouple CycC and Cdk8 from the core Mediator complex, leading to a reduction in CycC-dependent kinase activity ([@B24]).

Here we address the importance of CycC for M-phase progression in fission yeast. Our data support direct interactions between Med12 and CycC and suggest that the Cdk8--CycC interaction is stabilized within the Mediator complex. We find that CycC is required for correct timing of mitosis. Finally, we use a fusion between Cdk8 and CycC to study how Cdk8--CycC affects cell cycle progression outside the context of Mediator.

RESULTS
=======

CycC interacts with L-Mediator independently of Cdk8
----------------------------------------------------

We first characterized interactions between CycC and the Mediator. To this end, we used strains expressing TAP-tagged Med7 or CycC ([Figure 1](#F1){ref-type="fig"}). With TAP-Med7, we could isolate a mixture of L-Mediator and core Mediator in complex with Pol II, whereas TAP-CycC allowed us to isolate L-Mediator devoid of Pol II from a wild-type yeast background ([Figure 1](#F1){ref-type="fig"}, lane 2). We also isolated TAP-CycC from *med12*, *Δmed13*, and *Δcdk8* cells. TAP-CycC protein isolated from *Δmed12* and *Δmed13* did not associate with other Mediator components tested ([Figure 1](#F1){ref-type="fig"}, lanes 3--5), demonstrating that Med12 and Med13 are required for stable interactions between CycC and the Mediator complex. We observed no Cdk8 associated with the free TAP-CycC, suggesting that the Cdk8--CycC pair is unstable outside the context of the Mediator. Of interest, when purified from *Δcdk8* cells, some TAP-CycC remained associated with Mediator, demonstrating that CycC can interact with Mediator even in the absence of its kinase partner ([Figure 1](#F1){ref-type="fig"}, lane 4).

![CycC interacts with L-Mediator independently of Cdk8. Mediator complexes were purified with TAP-Med7 or TAP-CycC. Purified complexes were separated on 12% SDS--PAGE and immunoblotted with antibodies directed against the proteins indicated.](1738fig1){#F1}

CycC binds to the mitotic *ace2* promoter
-----------------------------------------

To investigate whether CycC associates in a periodic manner with mitotic promoters, we synchronized cells by *cdc25-22* block release and analyzed Myc-tagged CycC recruitment by time-resolved chromatin immunoprecipitation (ChIP) analysis. At 36°C (nonpermissive temperature), the *cdc25-22* mutation arrests cells in G~2~, which allows synchronized entry into mitosis when the cells are shifted back to 25°C (permissive temperature). We analyzed protein binding with quantitative real-time PCR and found that CycC interacted with the mitotic *ace2* promoter in a periodic manner. The peak of binding ([Figure 2](#F2){ref-type="fig"}) coincided with the peak of core Mediator recruitment to the same promoter (Med7-myc in [Figure 2](#F2){ref-type="fig"}). We can therefore conclude that CycC is recruited together with Mediator to mitotic promoters.

![Cyclin C binds to the mitotic *ace2* promoter together with the Mediator complex. Time-resolved ChIP of C-terminally tagged CycC-Myc and Med7-Myc proteins. Samples were collected at the indicated time points.](1738fig2){#F2}

Deletion of *cycc* delays mitotic entry
---------------------------------------

Next we investigated whether loss of CycC affects cell cycle progression. Using cells synchronized by *cdc25-22* block release, we compared septation indices for wild-type and *cyccΔ* cells. The mutant cells displayed delayed septation ([Figure 3A](#F3){ref-type="fig"}). We also analyzed the phosphorylation status of Tyr-15 on Cdk1 (the product of the *cdc2^+^* gene in fission yeast), which is a key event during mitotic entry. Cdk1--Tyr-15 dephosphorylation was delayed ∼15 min in *cyccΔ* mutant cells compared with a wild-type (wt) control ([Figure 3B](#F3){ref-type="fig"}). The observed delay in cell cycle progression in *cyccΔ* cells was similar to what we observed in *cdk8-D158A* kinase mutant ([@B22]) and *cdk8Δ* cells (unpublished data). Our data thus indicated that Cdk8 and CycC act in concert to promote cell cycle progression. In support of this notion, we observed no additive effects when both *cdk8* and *cycc* were deleted. The *cdk8Δ/cyccΔ* mutant displayed a delay in cell septation and Cdk1--Tyr-15 dephosphorylation ([Figure 4, A and B](#F4){ref-type="fig"}) similar to what we observed in *cyccΔ, cdk8Δ*, and *cdk8-D158A* cells ([@B22]), suggesting that they affect cell cycle progression via the same genetic pathway. In fact, a direct comparison revealed that the delay in septation was even more pronounced in *cyccΔ* than in *cdk8-D158A* kinase mutant cells ([Figure 4C](#F4){ref-type="fig"}).

![Cyclin C can regulate cell cycle progression. Deletion of the *cycc* gene results in (A) delayed septation and (B) delayed Cdc2-Tyr15 dephosphorylation.](1738fig3){#F3}

![Cyclin C and Cdk8 regulate cell cycle progression in the same genetic pathway. A *cdk8 cycC* double-deletion strain displays delayed septation (A) and delayed Cdc2--Tyr-15 dephosphorylation (B) similar to the single mutations ([Figure 3](#F3){ref-type="fig"}). (C) The delay in septation is more pronounced in *cyccΔ* than in *cdk8-D158A* cells.](1738fig4){#F4}

A CycC--L-Cdk8 fusion protein and its effect on cell cycle progression
----------------------------------------------------------------------

Our data suggested that CycC together with Cdk8 controls mitotic entry and that the interaction between these two proteins is stabilized within the context of the Mediator. We previously showed that deletion of *med12^+^ and med13^+^* can suppress the effects of *cdk8Δ* on cell cycle progression ([@B2]). We now observed that deletion of *med12^+^ and med13^+^* also suppressed the effects of *cyccΔ* on septation and Tyr-15 dephosphorylation ([Figure 5, A and B](#F5){ref-type="fig"}). The basis for the observed suppression is not clear, but we know that Cdk8 forms an active free pool when released from the Mediator by deletion of both *med12^+^* and *med13^+^* ([@B2]). On the basis of our biochemical characterization of L-Mediator ([Figure 1](#F1){ref-type="fig"}), we cannot exclude that deletion of *med12^+^* and/or *med13^+^* also leads to the formation of a free pool of CycC, raising the intriguing possibility that free Cdk8 or CycC may associate with other cyclins or Cdks and thereby affect cell cycle progression. To address this possibility, we restricted CycC interactions to Cdk8 by physically fusing the two proteins in vivo. The fusion gene, which also encoded 13-mer Myc-tag at the C-terminus, was used to replace the endogenous *cycc^+^* gene. We also deleted *cdk8^+^* in the strain expressing CycC--L-Cdk8, so that only one copy of the *cdk8^+^* gene would be present in the genome. We verified that the fusion protein was expressed as a full-length protein by immunoblot analysis ([Figure 5C](#F5){ref-type="fig"}). To ensure that the CycC--L-Cdk8 fusion protein could be incorporated into the Mediator, we used TAP-tagged Med7 to pull down Mediator complexes from wt and mutant strains using immunoglobulin G (IgG) beads ([Figure 5D](#F5){ref-type="fig"}). The CycC--L-Cdk8 fusion protein was associated with other Mediator components, and, as expected, it was lost in the *med12Δ med13Δ* mutant background. We also analyzed the timing of septation and Cdk1 Tyr-15 dephosphorylation and found that the CycC-L--Cdk8 fusion strain behaved like the *wt* control ([Figure 6, A and B](#F6){ref-type="fig"}).

![A CycC--L-Cdk8 fusion protein can associate with Mediator. The timing of (A) septation and (B) Cdc2-Tyr15 dephosphorylation is similar between a wt and a *cyccΔ med12Δ med13Δ* mutant strain. (C) The CycC--L-Cdk8 fusion protein (Myc-tagged) is expressed and migrates at the expected molecular weight. (D) CycC--L-Cdk8 associates with Mediator in wt cells (lane 7) but not in *med12Δ med13Δ* mutant cells (lane 8).](1738fig5){#F5}

![The CycC--L-Cdk8 fusion protein is active and does not affect cell cycle progression. CycC--L-Cdk8 fusion protein in *cdk8Δ* background shows normal (A) septation timing and (B) Cdc2--Tyr-15 dephosphorylation.](1738fig6){#F6}

We next investigated how deletion of *med12^+^* and *med13^+^* affected the timing of mitotic entry in the *CycC--L-Cdk8* fusion strain. We found that *med12Δmed13Δ* still resulted in early mitotic entry, as judged by Cdk1 Tyr-15 dephosphorylation ([Figure 7A](#F7){ref-type="fig"}). Therefore the observed effect on mitotic progression cannot be explained by interactions between Cdk8 and/or CycC with other cyclins or Cdks. In contrast, the fusion between CycC and Cdk8 prevented the early septation observed in *med12Δmed13Δ* cells. Timing of septation was similar between wt and *med12Δ med13Δ CycC-L-Cdk8* cells ([Figure 7B](#F7){ref-type="fig"}). A direct comparison demonstrated that septation was ∼20 min earlier in *med12Δ med13Δ* than in *med12Δ med13Δ CycC-L-Cdk8* cells ([Figure 7C](#F7){ref-type="fig"}).

![The CycC--L-Cdk8 fusion restores wt timing of septation in *med12Δ med13Δ* cells. CycC--L-Cdk8 fusion in *med12Δ med13Δ* background leads to (A) early dephosphorylation of Cdc2--Tyr-15 as compared with wt. The timing of septation in *CycC-L-Cdk8 med12Δ med13Δ* cells is similar to wt (B) and ∼20 min later than observed in *med12Δ med13Δ* cells (C).](1738fig7){#F7}

Septation coincides with S phase in synchronously dividing cells ([@B19]). We therefore followed up the septation observations using flow cytometry analysis to monitor the timing of DNA synthesis. We compared S-phase entry in synchronously dividing *med12Δ med13Δ* cells with S-phase entry in *med12Δmed13Δ* cells expressing the CycC--L-Cdk8 fusion construct. This analysis revealed that S phase was earlier in *med12Δmed13Δ* than in *med12Δ med13Δ CycC-L-Cdk8* cells ([Figure 8](#F8){ref-type="fig"}). On the basis of these observations, we conclude that a CycC--L-Cdk8 fusion counteracts the early S-phase entry caused by *med12Δ med13Δ*. It is possible that the fusion prevents CycC and Cdk8 from interacting with other S phase--promoting cyclins and Cdks outside the context of the Mediator complex.

![The CycC--L-Cdk8 fusion restores wt timing of S-phase entry in *med12Δmed13Δ* cells. Fluorescence-activated cell sorting analysis shows that *CycC-L-Cdk8 med12Δ med13Δ* cells do not display the early S-phase entry observed in *med12Δmed13Δ* cells.](1738fig8){#F8}

DISCUSSION
==========

In contrast to other cyclins involved in cell cycle progression, CycC does not oscillate. Instead, Cdk8/CycC activity appears to be regulated by other Mediator subunits. In line with a model previously suggested by others and us, we believe that Med12 and Med13 keep the Cdk8/CycC pair in a repressed state, which can be released when activators and/or signaling pathways induce structural changes in the Mediator complex ([@B23]). Loss of Med12 and/or Med13 may abolish this repressive effect, which explains the early entry into mitosis observed in *med12Δ* and *med13Δ* cells. In fact, loss of Med12 and Med13 leads to the release of CycC and Cdk8 from Mediator. We reasoned that a free pool of CycC and Cdk8 might affect cell cycle progression by interacting with alternative cyclins and Cdks. In support of this idea, a previous study of human CycC showed that the protein can interact with an alternative Cdk, namely CDK3 ([@B18]). To address this possibility experimentally, here we fused CycC to Cdk8, thereby restricting interaction to the cognate partner and analyzed the effects of *med12^+^* and *med13^+^* deletion on cell cycle progression. As demonstrated here, the effects of *med12Δmed13Δ* on mitotic progression are identical in the Cdk8--L-CycC strain to the effects observed in wt cells, strongly suggesting that Cdk8 and CycC act in concert to regulate timing of mitosis. Loss of Med12 and Med13 also causes early entry into S phase. Of interest, this effect is not observed in CycC--L-Cdk8 cells. The data suggest that eliminating the possibility for Cdk8 and CycC to interact with alternative cyclins and Cdks can restrict the effects of *med12^+^* and *med13^+^* deletions on cell cycle progression. Both overproduction of Cdk8 and mutations in CycC are observed in human tumors. It is tempting to speculate that these mutagenic changes may cause the formation of a free Cdk8 pool in mammalian cells, which could result in spontaneous interactions with alternative cyclins and promote S-phase progression. Limited information is available on the role of Cdk8 and CycC in M-phase progression in mammalian cells. We hope that our findings will stimulate others to elucidate whether the effects we observe in fission yeast are also conserved in higher organisms.

MATERIALS AND METHODS
=====================

Strains, media, and genetic methods
-----------------------------------

Standard molecular biology and molecular genetics methods were used ([@B16]). [Table 1](#T1){ref-type="table"} lists the strains used in this study. Primer sequences and conditions are available upon request. Cell culturing was performed using yeast extract liquid (YEL) or yeast extract agar supplemented with Geneticin (G418) or nourseothricin if required. Cells were grown at 25°C unless otherwise stated.

###### 

: Yeast strains used in this study.

  Strain    Genotype                                                                                           Source or reference
  --------- -------------------------------------------------------------------------------------------------- --------------------------------------
  CG-8      *med7+::TAP kanMX6 ade6-216 h-*                                                                    This study
  CG-15     *cdc25-22 h+*                                                                                      M. Sipiczki (University of Debrecen)
  CG-550    *CycC::13myc-NATMX6 cdc25-22 h+*                                                                   This study
  CG-45     *cdc25-22 med7+::myc-kanMX6 h-*                                                                    [@B22]
  CG-43     *cdk8::ura4+ ura4-D18 h+*                                                                          This study
  CG-406    *h^−^ med12::natMX4 med13::kanMX4 cdc25-22*                                                        [@B2]
  CG-559    *CyCC:kanMX4 med13::kanMX4 med12::nat-MX4 cdc25-22 h+*                                             This study
  CG-536    *CycC::kanMX4 cdc25-22 h+*                                                                         This study
  CG-565    *CycC::kanMX4 cdk8::ura4+ cdc25-22 h+*                                                             This study
  CG-574    *CycC-L-Cdk8-13myc-NATMX6 cdk8::ura4+ cdc25-22 h-*                                                 This study
  CG-575    *CycC-L-Cdk8-13myc-NATMX6 cdk8::ura4+ med13::kanMX4 med12::nat-MX4 cdc25-22 h-*                    This study
  CG-589    *CycC-L-Cdk8-13myc-NATMX6 med7::TAP-kanMX6 cdk8::ura4+ h-*                                         This study
  CG-595    *CycC-L-Cdk8-13myc-NATMX6 cdc25-22 med7::TAP-kanMX6 med13::kanMX4 med12::nat-MX4 cdk8::ura4+ h+*   This study
  TP42      *h^+^ ade6-M210 med7^+^-CTAP::G418^R^*                                                             [@B20]
  CGP101    *h^-^ spCycC^+^-CTAP::G418^R^*                                                                     This study
  CGPV105   *h^-^ Δmed12:: G418^R^ \_cycC^+^-CTAP::natMX*                                                      This study
  CGPV106   *h^-^ Δmed13::G418 ^R^ \_ cycC^+^-CTAP::natMX*                                                     This study
  CGPV107   *h^+^ cdk8::ura4^+^\_cycC^+^-CTAP::natMX*                                                          This study

C-terminally tagged CycC mutants were created using the pFA6-13myc-NATMX6 plasmid ([@B9]). PCR fragments were amplified from wild-type genomic DNA and cloned into *Pvu*II-*Pac*I and *Sac*I-*Eco*RV sites. The amplified plasmid was then digested by *Pvu*II and *Eco*RV enzymes and transformed into wild-type cells using the protocol described in [@B9]). The resulting colonies were then analyzed by PCR and immunoblotting.

CycC and Cdk8 were fused together via a linker region with the amino acid sequence GGGGSGGGGSGGGGS. The fused protein (CycC--L-Cdk8) was C-terminally tagged with a 13× Myc-tag. Briefly, cDNAs of the two genes and the linker sequence were amplified by standard PCR (KOD Hot Start DNA polymerase, 71086; Merck) and then fused together by overlap extension PCR. The resulting DNA fragment was cloned into the *Sal*I, *Pac*I site of the pFA6-13myc-NATMX6 plasmid. Sequences 500 base pairs long upstream and downstream of the wild-type *cycc* open reading frame were amplified by PCR and then fused together with the Myc-tagged CycC--L-Cdk8 construct by overlap extension PCR using the Expand Long Template PCR system (11681834001; Roche). The linear DNA was used to transform *cdk8Δ* cells following a previously described protocol ([@B9]). Resulting colonies were analyzed by PCR, DNA sequencing, and immunoblotting.

Protein methods and purification
--------------------------------

For purification of TAP-tagged Mediator, 15 l of yeast cell culture was grown to OD~600~ = 3.0--4.0 in YES (0.5% yeast extract, 3.0% glucose, 0.0225% adenine, 0.0225% histidine, 0.0225% leucine, 0.0225% uracil, and 0.0225% lysine) medium supplemented with 0.2 g/l adenine according to [@B21]). Briefly, cells were collected by centrifugation (2500 rpm for 7 min at 4°C; JA-10, Beckman Coulter), washed once with ice-cold water, and frozen in liquid nitrogen. Cells were broken in a Freezer/Mill 6850 (SPEX CertiPrep, NJ) using the following program: 10 min precooling and seven cycles with 2 min of beating and 2 min of rest at stringency 14. Broken cells were suspended in 0.5 ml of buffer A (200 mM KOH--4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.8, 15 mM KCl, 1.5 mM MgCl~2~, 0.5 mM EDTA, 15% glycerol, 0.5 mM dithiothreitol \[DTT\], and protease inhibitors) per gram of cell pellet. After the supernatant was cleared by centrifugation (at 9000 rpm for 15 min at 4°C; JA-10), one-ninth volume of 2 M KCl was added and stirred for 15 min. After ultracentrifugation (at 42,000 rpm for 20 min at +4°C; Ti45, Beckman Coulter), 500 µl of IgG beads (1 ml of slurry; Amersham Biosciences) was added and incubated for 1 h at 4°C. IgG beads were collected by centrifugation (at 1000 rpm for 2 min at 4°C; JA-17, Beckman Coulter), loaded into a column, and washed with 30 ml of IgG buffer (10 mM Tris-HCl, 150 mM KOAc, or 150 mM NaCl, pH 8.0). After washing with 20 ml of tobacco etch virus (TEV) protease cleavage buffer (10 mM Tris-HCl, 150 mM NaCl, 1 mM DTT, 0.5 mM EDTA, 0.05% NP-40, pH 8.0), Mediator was eluted by incubation for 1 h at 16°C with 200 U of TEV protease in 2 ml of TEV buffer.

Immunoblot analysis for Med17, Med18, and Med27 was performed as described in [@B21]). Recombinant *Schizosaccharomyces pombe* Cdk8 (amino acids \[aa\] 2--293), CycC (full length), and Med12 (aa 957--1148) and Med13 (aa 1--209) proteins fused to glutathione *S*-transferase (GST) was overproduced in *Escherichia coli* BL21 (DE3) pLysS cells (Stratagene) and purified from inclusion bodies as described ([@B6]). The purified GST-Cdk8, GST-CycC, and GST-Med12 were used to immunize rabbits, and GST-Med13 was used to immunize chicken (AgriSera, Vännäs, Sweden). Antibodies to detect the c-Myc tag (9E10) and pol II (8WG16) were both from Santa Cruz Biotechnology (Santa Cruz, CA).

Whole-cell extracts were produced from (1--4) × 10^8^ nonsynchronous or synchronous cultures grown in YEL medium. Cells were washed with ice-cold phosphate-buffered saline and immediately frozen at −20 or −80°C until further processing. Cells were lysed using a FastPrep machine for five cycles of 20 s of beating and 2 min of rest. We used the previously described lysis buffer for our experiments ([@B22]). CycC--Cdk8 fusion was detected by anti-Myc antibody (1:1000; M4439, Sigma-Aldrich). CoIP of the fusion protein was performed by adding 60 µl of IgG beads to the total cell extract and slowly rotating at 4°C. The beads were then washed with lysis buffer three times, eluted by 1× SDS loading buffer, and heated to 95°C for 5 min. Peroxidase--antiperoxidase antibody (1:1000; P1291, Sigma-Aldrich) was used for detection of the TAP-Med7 protein. The antibodies and their concentrations were previously described ([@B22]; [@B2]).

Chromatin immunoprecipitation
-----------------------------

ChIP experiments were performed as described previously ([@B22]). The ChIP DNA was analyzed with the Bio-Rad CFX96 Real-time PCR machine. All ChIP experiments were done at least twice and with two parallel IP repeats in each experiment. At least two PCR repeats were performed with all DNA samples. Fold change was calculated by comparing IP samples to no-antibody controls. Error bars indicate SD between IP repeats. For each cell cycle synchronization experiment, septation index was determined from counting at least 100 cells at each given time point.

Imaging methods
---------------

Native cell images for septation index experiments were taken with an Olympus CX41 microscope equipped with a DP70 camera.

Flow cytometry
--------------

Approximately 10^7^ cells were harvested for each time point, resuspended in 70% ethanol, and stored at 4°C until use. Flow cytometry measurement was performed using a BD FACSAria cell sorting system and the propidium iodide staining method ([www-bcf.usc.edu/\~forsburg/yeast-flow-cytometry.html](http://www-bcf.usc.edu/~forsburg/yeast-flow-cytometry.html)). Data analysis was done by using FlowJo ([www.flowjo.com](http://www.flowjo.com)) cell cytometry software.
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